Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880837 · ClinicalTrials.gov registry record · NA
Human Papillomavirus Education Programs
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04880837 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 12 participants.
The verdict
NCT04880837, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of the available vaccine. The initiative also addresses barriers to vaccination and refer people to sites where they can get the HPV vaccine (e.g., private doctor offices, community health clinics, school-based health centers, and health departments). The HPV education program may help increase HPV vaccination rates and ultimately prevent HPV-related cancers.
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- OTHER Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-04-27 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04880837
The ClinicalTrials.gov registry entry for NCT04880837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT04880837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04880837 about?
NCT04880837 is a clinical study titled "Human Papillomavirus Education Programs". This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of the available vaccine. The initiative also addresses barriers to vaccination and refer people to si...
What is the current status of trial NCT04880837?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-04-27. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04880837?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT04880837?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.